Brand:
Dragon Pharma, Europe
Manufacturer:
Dragon Pharma, Europe
Dosage Info:
<div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel">
<section class="tab-panel" id="panel-usage">
<h2>Dosage & Usage Guidelines</h2>
<div class="info-card warning">
<p><strong>For subcutaneous use after reconstitution.</strong> Dragontropin (Somatropin) is a recombinant human growth hormone supplied as a lyophilized powder. It must be reconstituted with <a href="/peptides-414/bacteriostatic-water-48726">bacteriostatic water</a> prior to administration.</p>
</div>
<h3>Administration Profile</h3>
<ul class="usage-highlights">
<li>✔ Lyophilized peptide requiring reconstitution</li>
<li>✔ Subcutaneous injection (preferred method)</li>
<li>✔ Typically administered daily or split into multiple doses</li>
</ul>
<p>After reconstitution, Dragontropin is commonly administered subcutaneously with rotation of injection sites to reduce local irritation. Daily administration is commonly used in Somatropin-based protocols, with dose selection adjusted according to response and tolerance</p>
<h3>Typical Use Context</h3>
<ul>
<li><strong>General wellness / lower-intensity protocols:</strong> 1–2 IU per day</li>
<li><strong>Recovery / body-composition focused protocols:</strong> 2–4 IU per day</li>
<li><strong>Higher-intensity protocols:</strong> 4–6 IU per day, often split into multiple administrations</li>
</ul>
<p>Higher daily amounts increase the likelihood of side effects and are generally approached more cautiously. Longer HGH protocols are often structured over multiple months rather than short anabolic-style cycles.</p>
<h3>Stacking Context</h3>
<p>Dragontropin is often used alongside structured nutrition, sleep, and training plans. In performance-focused settings it may also be paired with other compounds depending on individual goals, but protocol complexity should increase gradually.</p>
<h3>Possible Side Effects of Dragontropin</h3>
<ul>
<li>Water retention or edema</li>
<li>Tingling or numbness in the hands</li>
<li>Joint stiffness or discomfort</li>
<li>Changes in insulin sensitivity or blood glucose control</li>
<li>Injection-site irritation after reconstitution</li>
</ul>
<p>Side effects are often dose-related. If symptoms become pronounced, dose reduction or protocol adjustment is commonly considered. Blood glucose monitoring is a sensible precaution during longer or higher-dose use.</p>
<h3>Post-Use Considerations</h3>
<p>Post-cycle therapy (PCT) is not typically required when Dragontropin is used alone, since Somatropin does not function like a suppressive anabolic steroid. If used alongside suppressive compounds, recovery planning should reflect the full stack rather than HGH alone.</p>
<div class="info-card">
<p><strong>Important:</strong> Individual response varies. Dosing strategies and overall protocol design should be adjusted based on experience level, tolerance, and—where possible—bloodwork.</p>
</div>
</section>
</div>
Product Details
Active Substance
Somatropin (recombinant human growth hormone)
Formulation
Lyophilized Powder
Kit Size
200 IU total (10 × 20 IU vials)
Verified Assay
23.34 IU (7.78 mg)
116.70% of label claim · Batch #Unknown
Administration
Subcutaneous injection (after reconstitution)
Availability
USA Domestic & International
